You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR ALOPRIM

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ALOPRIM

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00181155 ↗	Intravenous Allopurinol in Heart Failure	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 2	2004-11-01	This study tests the hypothesis that allopurinol, a xanthine oxidase inhibitor, improves heart metabolism in patients with heart failure.
NCT00181155 ↗	Intravenous Allopurinol in Heart Failure	Completed	Johns Hopkins University	Phase 2	2004-11-01	This study tests the hypothesis that allopurinol, a xanthine oxidase inhibitor, improves heart metabolism in patients with heart failure.
NCT02956278 ↗	The Effects of BCRP Q141K on Allopurinol Pharmacokinetics and Dynamics	Completed	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Phase 4	2016-11-01	Subjects will undergo a placebo and allopurinol phase to better understand the effects of the reduced function BCRP Q141K variant on allopurinol pharmacokinetics and pharmacodynamics.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ALOPRIM

Condition Name

Chart
Table

Condition Name for ALOPRIM
Intervention	Trials
Chronic Gout	1
Congestive Heart Failure	1
Hyperuricemia	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ALOPRIM
Intervention	Trials
Small Cell Lung Carcinoma	1
Lung Neoplasms	1
Hyperuricemia	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ALOPRIM

Trials by Country

Map
Table

Trials by Country for ALOPRIM
Location	Trials
United States	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ALOPRIM
Location	Trials
Missouri	1
California	1
Maryland	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ALOPRIM

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ALOPRIM
Clinical Trial Phase	Trials
Phase 4	1
Phase 2	1
Phase 1/Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ALOPRIM
Clinical Trial Phase	Trials
Completed	2
Not yet recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ALOPRIM

Sponsor Name

Chart
Table

Sponsor Name for ALOPRIM
Sponsor	Trials
Open Medicine Institute	1
University of California, San Francisco	1
Washington University School of Medicine	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ALOPRIM
Sponsor	Trials
Other	4
NIH	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.